(Reuters) - Biogen shareholders elected former company executive Susan Langer as a director on Monday, weeks after her romantic partner, Alex Denner, .
Proxy advisory firm Institutional Investor Services urged Alkermes shareholders to elect one of three director candidates proposed by activist hedge fund Sarissa Capital, arguing more outside. | June 20, 2023
Proxy advisory firm Institutional Shareholder Services on Thursday recommended that Biogen shareholders elect Susan Langer to replace long-standing director Alex Denner, who abruptly left the board earlier this week. Biogen said Langer, a former corporate strategy chief at the biotech company, would stand for election to replace Denner. ISS issued its recommendation after the unexpected announcement on Monday that three directors Denner, William Jones and Richard Mulligan would not stand for reelection.
ISS backs election of Langer to replace former Biogen director Denner streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his…